Sitravatinib

Sitravatinib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T4349-5mg 5 mg

7 - 10 business days*

45.00€
TGM-T4349-1mL 1 ml

7 - 10 business days*

62.00€
TGM-T4349-10mg 10 mg

7 - 10 business days*

68.00€
TGM-T4349-25mg 25 mg

7 - 10 business days*

131.00€
TGM-T4349-50mg 50 mg

7 - 10 business days*

209.00€
TGM-T4349-100mg 100 mg

7 - 10 business days*

335.00€
TGM-T4349-200mg 200 mg

7 - 10 business days*

532.00€
TGM-T4349-500mg 500 mg

7 - 10 business days*

842.00€
 
Description: Sitravatinib (MGCD516) is an inhibitor targeting multiple RTKs involved in driving... more
Product information "Sitravatinib"
Description: Sitravatinib (MGCD516) is an inhibitor targeting multiple RTKs involved in driving sarcoma cell growth, including c-Met, c-Kit, PDGFRalpha/beta, PDGFR, and Axl. Target: VEGFR, Trk receptor, TAM Receptor, c-Kit, Ephrin Receptor, FLT, Discoidin Domain Receptor (DDR). Smiles: COCCNCc1ccc(nc1)-c1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)c2s1. References: Patwardhan PP et al. Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preClinicalal models of sarcoma. Oncotarget, 2016 Jan 26,7(4):4093-109.
Keywords: MG516, MGCD516
Supplier: TargetMol
Supplier-Nr: T4349

Properties

Application: Targets AXL receptor tyrosine kinase [EC:2.7.10.1] (AXL, UFO)
MW: 629.68 D
Formula: C33H29F2N5O4S

Database Information

CAS : 1123837-84-2| Matching products
KEGG ID : K05096 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Sitravatinib"
Write a review
or to review a product.
Viewed